chevron_leftBack
As of 27 June 2026, Evoq Remedies Ltd. has a market cap of $951.54K USD, ranking #48650 globally and #5085 in India.
It ranks #4317 in the Healthcare sector, and #1358 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$951.54KUSD
89.89M INR
Enterprise Value
$919.76KUSD
86.81M INR
Revenue (TTM)
$4.31MUSD
407.29M INR
EBITDA (TTM)
$201.59KUSD
19.03M INR
Net Income (TTM)
$187.04KUSD
17.67M INR
EBITDA Margin
4.7%
Profit Margin
4.3%
PE Ratio
5.3
PS Ratio
0.2
PB Ratio
0.2
EV/EBITDA
4.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Bhumishth Patel
open_in_new
Founded
2010
Website
evoqremedies.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.9% | -5.2% | 46% | 18% | -38% | 15% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
543500
(EVOQ)
Evoq Remedies Ltd
ISIN: INE0JVD01011
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
3.61 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Evoq Remedies Ltd.
Evoq Remedies Limited engages in the pharmaceutical business in India. The company trades in and acts as a commission agent for pharmaceutical products. It also manufactures, distributes, and exports commercial grade, refined, pale pressed grade, and first pressed degummed castor oils; castor oil and de oil cakes; and high protein castor meals. Evoq Remedies Limited was incorporated in 2010 and is based in Ahmedabad, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$45.18B
5M%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.36B
2M%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$15.16B
2M%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.72B
1M%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.86B
1M%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.7B
1M%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
80M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
58M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
38M%
|
97.4
|
|
SIX: RO
|
$316.45B
33M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.53B
30M%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
29M%
|
15.1
|
chevron_leftBack